Intriguingly, platelet factor 4 (PF4), an endocrine factor with overexpression correlating with decreased overall survival of patients with lung cancer [27], emerged as a central node connected with high confidence to SRGN, SPARC, CLU and CCL5 (Fig. 3a). Here, CLU is linked to lung cancer.